Literature DB >> 25311227

Atrial fibrillation: Challenging the status quo: β-blockers for HF plus AF.

Paul Khairy1, Denis Roy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25311227     DOI： 10.1038/nrcardio.2014.166

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).

Authors:  J W BLACK; J S STEPHENSON
Journal:  Lancet       Date:  1962-08-18       Impact factor: 79.321

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

3.  Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

Authors:  Sana M Al-Khatib; Joo Y Han; Rex Edwards; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Riccardo Cappato; Paul Dorian; Al Hallstrom; Alan H Kadish; Peter J Kudenchuk; Kerry L Lee; Daniel B Mark; Arthur J Moss; Richard Steinman; Lurdes Y T Inoue; Gillian D Sanders
Journal:  Int J Cardiol       Date:  2014-01-10       Impact factor: 4.164

4.  Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.

Authors:  Julia Cadrin-Tourigny; D G Wyse; Denis Roy; Lucie Blondeau; Sylvie Levesque; Mario Talajic; Jason G Andrade; Marc Dubuc; Bernard Thibault; Peter G Guerra; Laurent Macle; Lena Rivard; Paul Khairy
Journal:  J Cardiovasc Electrophysiol       Date:  2014-10-07

5.  Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation.

Authors:  Mario Talajic; Paul Khairy; Sylvie Levesque; Stuart J Connolly; Paul Dorian; Marc Dubuc; Peter G Guerra; Stefan H Hohnloser; Kerry L Lee; Laurent Macle; Stanley Nattel; Ole D Pedersen; Lynne Warner Stevenson; Bernard Thibault; Albert L Waldo; D George Wyse; Denis Roy
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.

Authors:  Dipak Kotecha; Jane Holmes; Henry Krum; Douglas G Altman; Luis Manzano; John G F Cleland; Gregory Y H Lip; Andrew J S Coats; Bert Andersson; Paulus Kirchhof; Thomas G von Lueder; Hans Wedel; Giuseppe Rosano; Marcelo C Shibata; Alan Rigby; Marcus D Flather
Journal:  Lancet       Date:  2014-09-02       Impact factor: 79.321

8.  Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

Authors:  Eileen O'Meara; Paul Khairy; Malorie Chabot Blanchet; Simon de Denus; Ole D Pedersen; Sylvie Levesque; Mario Talajic; Anique Ducharme; Michel White; Normand Racine; Jean-Lucien Rouleau; Jean-Claude Tardif; Denis Roy
Journal:  Circ Heart Fail       Date:  2012-07-12       Impact factor: 8.790

9.  Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.

Authors:  Dipak Kotecha; Luis Manzano; Douglas G Altman; Henry Krum; Guliz Erdem; Nicola Williams; Marcus D Flather
Journal:  Syst Rev       Date:  2013-01-18
  9 in total
  2 in total

Review 1.  How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.

Authors:  Rose Mary Ferreira Lisboa da Silva; Anaisa Silva Roever Borges; Nilson Penha Silva; Elmiro Santos Resende; Gary Tse; Tong Liu; Leonardo Roever; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

2.  Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.

Authors:  Athanasius Wrin Hudoyo; Hiroki Fukuda; Miki Imazu; Kazuhiro Shindo; Haiying Fu; Yuko Iwata; Shin Ito; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2019-06-18       Impact factor: 3.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.